Related Experiment Video
Updated: Mar 7, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
LRRK2: from kinase to GTPase to microtubules and back
Marian Blanca Ramírez1, Antonio Jesús Lara Ordóñez1, Elena Fdez1
1Institute of Parasitology and Biomedicine 'López-Neyra', Consejo Superior de Investigaciones Científicas (CSIC), Avda del Conocimiento s/n, 18016 Granada, Spain.
Abstract:
Mutations in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene are intimately linked to both familial and sporadic Parkinson's disease. LRRK2 is a large protein kinase able to bind and hydrolyse GTP. A wealth of in vitro studies have established that the distinct pathogenic LRRK2 mutants differentially affect those enzymatic activities, either causing an increase in kinase activity without altering GTP binding/GTP hydrolysis, or displaying no change in kinase activity but increased GTP binding/decreased GTP hydrolysis. Importantly, recent studies have shown that all pathogenic LRRK2 mutants display increased kinase activity towards select kinase substrates when analysed in intact cells. To understand those apparently discrepant results, better insight into the cellular role(s) of normal and pathogenic LRRK2 is crucial. Various studies indicate that LRRK2 regulates numerous intracellular vesicular trafficking pathways, but the mechanism(s) by which the distinct pathogenic mutants may equally interfere with such pathways has largely remained elusive. Here, we summarize the known alterations in the catalytic activities of the distinct pathogenic LRRK2 mutants and propose a testable working hypothesis by which the various mutants may affect membrane trafficking events in identical ways by culminating in increased phosphorylation of select substrate proteins known to be crucial for membrane trafficking between specific cellular compartments.
Insights
Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are linked to Parkinson's disease. Pathogenic LRRK2 mutants may disrupt cellular membrane trafficking identically by increasing substrate phosphorylation.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Mutations in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene are a significant cause of familial and sporadic Parkinson's disease.
- LRRK2 is a protein kinase involved in GTP binding and hydrolysis, with its enzymatic activities altered in pathogenic mutants.
Purpose of the Study:
- To reconcile discrepant in vitro and cellular findings regarding LRRK2 mutant activities.
- To elucidate the cellular roles of normal and pathogenic LRRK2 in intracellular vesicular trafficking.
- To propose a unifying hypothesis for how LRRK2 mutants affect membrane trafficking.
Main Methods:
- Review and summarization of known alterations in the catalytic activities of distinct pathogenic LRRK2 mutants.
- Analysis of recent studies on LRRK2 mutant activity in intact cells.
- Formulation of a testable working hypothesis based on existing data.
Main Results:
- In vitro studies show differential effects of LRRK2 mutants on kinase activity and GTP binding/hydrolysis.
- Cellular studies indicate that all pathogenic LRRK2 mutants increase kinase activity towards specific substrates.
- Existing data suggest LRRK2 regulates intracellular vesicular trafficking pathways.
Conclusions:
- Pathogenic LRRK2 mutants may converge on a common mechanism to disrupt membrane trafficking.
- This disruption likely involves increased phosphorylation of key substrate proteins crucial for vesicular transport.
- Further research is needed to validate the proposed hypothesis and understand the precise cellular mechanisms involved.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Receptor Tyrosine Kinases
Microtubule Associated Proteins (MAPs)
GTPases and their Regulation
Large G-proteins,...

